AsiaBiome was a headline speaker at Pharmabiotics 2019 in Paris. Co-founder and CEO Jonathan Krive presented on The Asian Gut Microbiome, a New Therapeutics Discovery Opportunity.
In his presentation, Mr Krive explained that the Asia gut microbiome is not homogeneous, but very heterogeneous, and unique from the gut microbiomes of many western countries. He also introduced the AsiaBiome proprietary live biotherapeutic drug discovery platform, including three lead candidates in IBS, autism, and type 2 diabetes.
For a copy of his presentation, please contact email@example.com